Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 328

The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.

Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s Disease

Open access
Le Douce, Juliette, Maugard, Marianne, Veran, Julien, Matos, Marco, Jégo, Pierrick, Vigneron, Pierre-Antoine, Faivre, Emilie, Toussay, Xavier, Vandenberghe, Michel, Balbastre, Yaël, Piquet, Juliette, Guiot, Elvire, Tran, Nguyet Thuy, Taverna, Myriam, Marinesco, Stéphane, Koyanagi, Ayumi, Furuya, Shigeki, Gaudin-Guérif, Mylène, Goutal, Sébastien, Ghettas, Aurélie, Pruvost, Alain, Bemelmans, Alexis-Pierre, Gaillard, Marie-Claude, Cambon, Karine, Stimmer, Lev, Sazdovitch, Véronique, Duyckaerts, Charles, Knott, Graham, Hérard, Anne-Sophie, Delzescaux, Thierry, Hantraye, Philippe, Brouillet, Emmanuel, Cauli, Bruno, Oliet, Stéphane H.R., Panatier, Aude, Bonvento, Gilles·2020·Cell Metabolism

Abstract

Alteration of brain aerobic glycolysis is often observed early in the course of Alzheimer's disease (AD). Whether and how such metabolic dysregulation contributes to both synaptic plasticity and behavioral deficits in AD is not known. Here, we show that the astrocytic l-serine biosynthesis pathway, which branches from glycolysis, is impaired in young AD mice and in AD patients. l-serine is the precursor of d-serine, a co-agonist of synaptic NMDA receptors (NMDARs) required for synaptic plasticity. Accordingly, AD mice display a lower occupancy of the NMDAR co-agonist site as well as synaptic and behavioral deficits. Similar deficits are observed following inactivation of the l-serine synthetic pathway in hippocampal astrocytes, supporting the key role of astrocytic l-serine. Supplementation with l-serine in the diet prevents both synaptic and behavioral deficits in AD mice. Our findings reveal that astrocytic glycolysis controls cognitive functions and suggest oral l-serine as a ready-to-use therapy for AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2020.02.004

Cites

72 of 72 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 72 references

Cited by

See all 328

Metadata

Authors
Le Douce, J., Maugard, M., Veran, J., Matos, M., Jégo, P., Vigneron, P.-A., Faivre, E., Toussay, X., Vandenberghe, M., Balbastre, Y., Piquet, J., Guiot, E., Tran, N. T., Taverna, M., Marinesco, S., Koyanagi, A., Furuya, S., Gaudin-Guérif, M., Goutal, S., Ghettas, A., Pruvost, A., Bemelmans, A.-P., Gaillard, M.-C., Cambon, K., Stimmer, L., Sazdovitch, V., Duyckaerts, C., Knott, G., Hérard, A.-S., Delzescaux, T., Hantraye, P., Brouillet, E., Cauli, B., Oliet, S. H. R., Panatier, A., & Bonvento, G.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2020-03
Volume
31
Issue
3
Pages
503-517.e8
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2971770812
Cited by
328
References
72
FWCI
13.00
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s Disease. https://app.cochat.ai/papers/10.1016/j.cmet.2020.02.004
The paper
Le Douce, J., Maugard, M., Veran, J., Matos, M., Jégo, P., Vigneron, P.-A., Faivre, E., Toussay, X., Vandenberghe, M., Balbastre, Y., Piquet, J., Guiot, E., Tran, N. T., Taverna, M., Marinesco, S., Koyanagi, A., Furuya, S., Gaudin-Guérif, M., Goutal, S., . . . Bonvento, G. (2020). Impairment of Glycolysis-Derived l-Serine Production in Astrocytes Contributes to Cognitive Deficits in Alzheimer’s Disease. Cell Metabolism. https://doi.org/10.1016/j.cmet.2020.02.004

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.